1-methyl-4-phenyl-2,3-dihydropyridinium has been researched along with Parkinson Disease in 3 studies
*Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brunner, T; Cirri, E; Ferger, B; Friemel, A; Hiller, K; Karreman, C; Leist, M; Marx, A; Meiser, J; Möller, HM; Odermatt, M; Pape, R; Pasquarelli, N; Ringwald, M; Schildknecht, S; Strittmatter, T | 1 |
| Coates, PW; Everse, J | 1 |
| Beckley, DJ; Bloem, BR; Remler, MP; Roos, RA; van Dijk, JG; Zwinderman, AH | 1 |
3 other study(ies) available for 1-methyl-4-phenyl-2,3-dihydropyridinium and Parkinson Disease
| Article | Year |
|---|---|
Preferential Extracellular Generation of the Active Parkinsonian Toxin MPP+ by Transporter-Independent Export of the Intermediate MPDP+.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Astrocytes; Biological Transport; Catecholamines; Cell Line; Cell Membrane; Diffusion; Dopaminergic Neurons; Extracellular Fluid; Humans; Monoamine Oxidase; Oxidation-Reduction; Parkinson Disease; Pyridinium Compounds | 2015 |
The cytotoxic activity of lactoperoxidase: enhancement and inhibition by neuroactive compounds.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Apomorphine; Aspirin; Brain; Catalysis; Cell Line, Tumor; Dogs; Dopamine; Erythrocytes; Free Radicals; Herbicides; Humans; Lactoperoxidase; Neurons; Parkinson Disease; Peroxidase; Pyridinium Compounds; Spectrophotometry; Time Factors; Uric Acid | 2004 |
Influence of dopaminergic medication on automatic postural responses and balance impairment in Parkinson's disease.
Topics: Adult; Aged; Dopamine Agents; Female; Humans; Male; Middle Aged; Motor Skills; Parkinson Disease; Postural Balance; Posture; Pyridinium Compounds | 1996 |